GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | GSK3B | multiple interactions | EXP | | 6480464 | CTD | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSK3B mRNA; dorsomorphin inhibits the reaction [ginsenoside Rg2 results in increased phosphorylation of GSK3B protein]; dorsomorphin inhibits the reaction [Resveratrol results in decreased activity of GSK3B protein]; dorsomorphin inhibits the reaction [Resveratrol results in increased phosphorylation of GSK3B protein] | PMID:19620254 PMID:22062806 PMID:27188386 | GSK3B | multiple interactions | ISO | Gsk3b (Mus musculus) | 6480464 | CTD | dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose] | PMID:22180358 | |
Go Back to source page | Continue to Ontology report |